[DOPA-responsive dystonia (Segawa's disease)].
Bobylova
M Iu
MIu
Mikhaĭlova
S B
SB
Grinio
L P
LP
D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000627:therapeutic use; D015259:Dopamine Agents / Q000009:adverse effects* / Q000627:therapeutic use; D020821:Dystonic Disorders / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D019966:Substance-Related Disorders
D015259:Dopamine Agents; D004295:Dihydroxyphenylalanine